AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

Q: What does CUSIP 00847X104 represent in this 13F holders report?

CUSIP 00847X104 is the security identifier for AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share in Q1 2023?

161 institutional investors reported AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share for Q1 2023. Use the holders table for investor-level position and value details.

CUSIP: 00847X104

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock, Par Value $0.001 per share
Shares outstanding: 59,431,072
Total 13F shares: 58,996,438
Share change: -369,743
Total reported value: $1,355,139,176
Put/Call ratio: 181%
Reported price per share: $22.97
Number of holders: 161
Value change: -$9,985,145
Number of buys: 76
Number of sells: 69

Security key

00847X104

Report period

Q1 2023

Institutions

161

Top holders

AGIO full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2023 Previous quarter: Q4 2022 AGIOS PHARMACEUTICALS, INC. SEC filings AGIOS PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 00847X104

Newer quarter: Q2 2023 Previous quarter: Q4 2022

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

WELLINGTON MANAGEMENT GRO...

13D/G signal

—

Evidence rows

Latest as of

31 Dec 2022

13F Lead comparable stake: 9.2% Showing 1-6 of 15 holder rows.

Rank 1 holder

WELLINGTON MANAGEMENT GROUP LLP

13F

Ownership: 9.2%
Position: $153.39M

13F

Rank 2 holder

VANGUARD GROUP INC

13F

Ownership: 9%
Position: $149.81M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	9.2%	$153,391,408 5,462,657 shares	—	31 Dec 2022
VANGUARD GROUP INC	13F Company 13F	9%	$149,808,934 5,335,076 shares	—	31 Dec 2022
BlackRock Finance, Inc.	13F Company 13F	8%	$133,909,982 4,768,874 shares	—	31 Dec 2022
Bellevue Group AG	13F Company 13F	6.8%	$113,914,719 4,056,792 shares	—	31 Dec 2022
STATE STREET CORP	13F Company 13F	5.3%	$89,268,229 3,179,068 shares	—	31 Dec 2022
Rock Springs Capital Management LP	13F Company 13F	5%	$84,144,303 2,996,592 shares	—	31 Dec 2022

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

161

58,996,438

Rows available

161

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

156

Q1 2023 holders

161

Holder diff

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 value	Q1 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend